Literature DB >> 415008

Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.

N S Taylor, M Pollack.   

Abstract

Pseudomonas aeruginosa exotoxin A was purified by affinity chromatography from culture supernatants by elution of toxin from antitoxin immunoglobulin G-Sepharose 4B with 3 M NaSCN. The purity, toxicity, and enzymatic activity of exotoxin obtained were comparable to those of toxin purified by previously reported multiple-step procedures.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415008      PMCID: PMC414049          DOI: 10.1128/iai.19.1.66-70.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Use of microculture plates and the multiple automated sample harvester for in vitro microassay of bacterial toxins.

Authors:  R C Knudsen; L T Callahan; A Ahmed; K W Sell
Journal:  Appl Microbiol       Date:  1974-08

5.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa.

Authors:  D W Chung; R J Collier
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

6.  Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.

Authors:  S H Leppla
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

7.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.

Authors:  M Pollack; N S Taylor
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

9.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Incidence of exotoxin production by Pseudomonas species.

Authors:  M J Bjorn; M L Vasil; J C Sadoff; B H Iglewski
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more
  14 in total

Review 1.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

2.  Enzyme-linked immunosorbent assay for Pseudomonas aeruginosa exotoxin A.

Authors:  W W Schultz; T J Phipps; M Pollack
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

3.  Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.

Authors:  M J Bjorn; O R Pavlovskis; M R Thompson; B H Iglewski
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

4.  Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium.

Authors:  J D Klinger; B Tandler; C M Liedtke; T F Boat
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

5.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

6.  In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

Authors:  R U Sorensen; J D Klinger; H A Cash; P A Chase; D G Dearborn
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

7.  Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization.

Authors:  D E Ohman; J C Sadoff; B H Iglewski
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A.

Authors:  J K Chia; M Pollack; D Avigan; S Steinbach
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.609

9.  Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.

Authors:  Joseph Ryan Polli; Ping Chen; Brandon M Bordeau; Joseph P Balthasar
Journal:  AAPS J       Date:  2022-03-25       Impact factor: 3.603

10.  Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.

Authors:  K W Klinger; C W Shuster; J Klinger
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.